Presentation Information
[15-2-03]Dimpropyridaz (Axalion®): a chordotonal organ modulator with a new mode of action
*Barbara Wedel1, James Machamer1, Vincent L. Salgado1, Martin Göpfert2 (1. BASF Corporation (United States of America), 2. University of Göttingen (Germany))
Password required to view
Abstract password authentication.
A PDF file of the entire program will be available soon.
※Password is required to see the abstract. (Only for ICE2024 Registrants.)
A PDF file of the entire program will be available soon.
※Password is required to see the abstract. (Only for ICE2024 Registrants.)
